Skip to content

Correlation Analysis of Covid-19 IgG Antibody Level in Seminal Plasma and Semen Index

Association of Seminal Plasma SARS-Cov19 IgG Level With Semen Parameters and Embryological Characteristics in Vaccinated Normozoospermic Men

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05212506
Enrollment
100
Registered
2022-01-28
Start date
2022-01-31
Completion date
2022-05-31
Last updated
2022-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, IgG Antibody, Semen Index

Brief summary

Since December 2019, more and more cases of unexplained pneumonia appeared after exposure to the South China Seafood Market in Wuhan City, Hubei Province. Later, the disease were confirmed to be acute respiratory infectious diseases caused by the 2019 new coronavirus infection. Even though we have had great victories in the war against this pandemic, there is still a very large number of deaths early on. As research progresses, vaccines for this infectious disease are already being developed. There are currently two vaccines in widespread use worldwide: mRNA vaccines and inactivated vaccines. In China, inactivated vaccines are more commonly used. At present, some studies believe that mRNA vaccine does not affect the pregnancy rate and abortion rate of women, but the study sample size is small, and the conclusions are limited. The effects of inactivated vaccines on fertility are still in the blank. We now hope to conduct prospective studies, mainly to study the effect of inactivated vaccine injection on male semen, and whether it has an effect on the quality of embryos in IVF patients

Interventions

BIOLOGICALvaccinated and unvaccinated

the vaccinated :Male patients who received more than 2 injections of the covid-19 vaccine;the unvaccinated :Male patients who did not receive the covid-19 vaccine

Sponsors

Shanghai First Maternity and Infant Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
22 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. The man's semen quality is normal, 2. The couple meets the indications for IVF, 3. injected with the covid-19 vaccine

Exclusion criteria

1. In vitro fertilization due to male factors 2. Azoospermia 3. The quality of the man's semen is abnormal 4. unvacced

Design outcomes

Primary

MeasureTime frameDescription
semen index2022.01-2022.03the semen index of the participants

Secondary

MeasureTime frameDescription
Fertilization rate2022.01-2022.04The percentage of eggs fertilized
embryo quality2022.02-2022.05Grading of formed embryos
clinical pregnant rate2022.03-2022.05after the embryo transplantation, calculate the pregnancy rate

Countries

China

Contacts

Primary Contactqiang yan
602172356@qq.com18205184018

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026